Skip to main content
Clinical Trials/NCT07148609
NCT07148609
Active, not recruiting
Not Applicable

Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients: A Randomized Controlled Parallel-group Pilot Trial.

TsaoTun Psychiatric Center, Department of Health, Taiwan1 site in 1 country64 target enrollmentStarted: May 3, 2025Last updated:

Overview

Phase
Not Applicable
Status
Active, not recruiting
Sponsor
TsaoTun Psychiatric Center, Department of Health, Taiwan
Enrollment
64
Locations
1
Primary Endpoint
The changes of quality of life

Overview

Brief Summary

The goal of this clinical trial is to learn if video game-facilitated group activity helps to improve the quality of life and social function in inpatients with chronic schizophrenia.

The main questions it aims to answer are:

  • Does video game-facilitated group activity enhance the quality of life as measured by a standardized scale (WHOQOL) in patients with schizophrenia hospitalized in a psychiatric hospital?
  • Can video game-facilitated group activity promote social function as measured by a specific scale (PSP) in patients with schizophrenia hospitalized in a psychiatric hospital?

Researchers will compare video game-facilitated group activity to regular occupational therapy to see if the intervention is beneficial to patients with chronic schizophrenia.

Participants will:

  • Attend to video game-facilitated group activity or regular occupational therapy three times a week for 12 weeks.
  • Receive assessments upon and after the 12-week intervention, and another 12 weeks after the intervention ends.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
20 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Individuals aged between \>18 and \<65 years with a principal diagnosis of schizophrenia, as defined by the International Classification of Diseases (ICD-10) codes F20.0-F20.9 which was diagnosed according to DSM-5-TR criteria.
  • Possessing a valid Catastrophic Illness Certificate for schizophrenia and being continuously hospitalized for more than six months.
  • Being able to read Chinese and communicate effectively in either Mandarin or Taiwanese.
  • Being able to comprehend the purpose of the study and to provide written informed consent after the study has been explained by the researchers.

Exclusion Criteria

  • Individuals exhibiting unstable psychiatric or consciousness conditions, or those unable to comply with video game-based instruction and operation.
  • Individuals with a history of ocular diseases, severe cardiovascular disorders, epilepsy, or brain injuries; or those who have experienced acute cardiovascular or cerebrovascular events, bone fractures, undergone hip or knee joint replacement, or present with lower limb balance impairments or structural injuries-such as amputations, post-lumbar surgery status, or acute ankle sprains-rendering participation unsuitable within the past six months.
  • Concurrent participation in other research studies during the study period, where the intervention may potentially influence the primary or secondary outcomes of this study.
  • Individuals who are legally declared under guardianship.

Outcomes

Primary Outcomes

The changes of quality of life

Time Frame: The outcome will be assessed at baseline, week 12, and week 24.

The changes of quality of life will be assessed by the World Health Organization Quality of Life-BREF (WHOQOL-BREF).

The changes of social function.

Time Frame: The outcome will be assessed at baseline, week 12, and week 24

The changes of social function will be evaluated by the Personal and Social Performance Scale (PSP).

Secondary Outcomes

  • The changes of cerebral blood flow.(The outcome will be assessed at baseline and week 12.)
  • The change of cognitive function.(The outcome will be assessed at baseline and week 12.)
  • The change of psychiatric symptoms.(The outcome will be assessed at baseline and week 12.)
  • The change of physical fitness(The outcome will be assessed at baseline and week 12.)

Investigators

Sponsor
TsaoTun Psychiatric Center, Department of Health, Taiwan
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Wei-Yu Chiang

Resident psychiatrist

TsaoTun Psychiatric Center, Department of Health, Taiwan

Study Sites (1)

Loading locations...

Similar Trials